- Taficita™ (Tenofovir Alafenamide) is a novel Tenofovir prodrug with a 90% reduction in plasma Tenofovir concentrations.
- Tenofovir Alafenamide containing regimens have improved bone safety compared with Tenofovir Disoproxil Fumarate containing regimens.
- Taficita™ is indicated in people who weigh at least 77 pounds (35 kg)

Please refer to the manufacturer’s website to learn all the information needed to use this medicine safely and effectively
Reviews
There are no reviews yet.